Table 1 Clinical data
From: High-dose intravenous glucocorticoid induces hyperamylasemia: a case series
Case | Age/sex | Primary disease | Main symptoms | mPSL dose | AMY peak (U/L) | New symptoms | Other therapeutic drugs | Outcome |
|---|---|---|---|---|---|---|---|---|
1 | 49/F | ADEM | Fever, headache, jet vomiting | 500 mg/day for 7 days + 250 mg/day for 5 days + 120 mg/day for 5 days | 336.9 | Abdominal pain | Ceftriaxone sodium, acyclovir | Better |
2 | 26/F | ADEM | Fever, headache, dysuria | 80 mg q8h 2 days + 120 mg/day for 2 days + 200 mg/day for 2 days + 120 mg/day for 2 days | 340.4 | Abdominal distension, abdominal pain | Ceftriaxone sodium, acyclovir, piperacillin tazobactam | Better |
3 | 51/F | SLE | Tooth loss, abdominal pain, dry mouth, knee joint pain | 500 mg/day for 3 days | 193.1 | None | Cefotiam, cyclophosphamide | Discharged |
4 | 71/F | Uremia, nephrotic syndrome | Gross hematuria, edema | 250 mg/day for 3 days + 250 mg/day 3 days | 257.9 | None | Piperacillin tazobactam, cyclophosphamide | Discharged |